This drug is being investigated for its efficacy against solid tumors, because PKN3 knockdown may prevent metastasis by reducing vascular leakiness and tumor cell migration and tumor lymphangiogenesis and hemangiogenesis. Here, PKN3 is linked to neoplasm.